2019 Seeing Beyond Lecture #2
Date: 2/10/2019
Venue: Theatre 1, 207-221 Bouverie Street (School of Population Health – Bldg 379), University of Melbourn, VIC, 3010
Provider: University of Melbourne
Contact: Laura Downie, [E] ldownie@unimelb.edu.au, [P] 0402 543 070
Learning Objectives
- To gain a general understanding of ocular gene therapy technologies.
- To understand which ocular diseases are likely to be amenable to gene therapy interventions.
- To appreciate optimal patient selection for potential gene therapy interventions.
- To appreciate the challenges that arise when attempting to treat complex eye diseases with gene therapy.
- To gain a general understanding of the current clinical applicability of ocular gene therapies.
- To learn about the potential future possibilities of gene therapy for treating eye disease.
Max points awarded: 6.00
Session Information
| Name |
|---|
| Gene therapy: scientific concepts and patient considerations |
| Activity Type |
| Face to Face with Assessment |
| Therapeutic? |
| Yes |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 3.00 |
| Name |
|---|
| Gene therapy: treatments for glaucoma and inherited retinal degeneration |
| Activity Type |
| Face to Face with Assessment |
| Therapeutic? |
| Yes |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 3.00 |